The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease

The prevalence of non‐alcoholic fatty liver disease (NAFLD) continues to increase dramatically, and there is no approved medication for its treatment. Recently, we predicted the underlying molecular mechanisms involved in the progression of NAFLD using network analysis and identified metabolic cofac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cheng, Bjornson, Elias, Arif, Muhammad, Tebani, Abdellah, Lovric, Alen, Benfeitas, Rui, Ozcan, Mehmet, Juszczak, Kajetan, Kim, Woonghee, Kim, Jung Tae, Bidkhori, Gholamreza, Ståhlman, Marcus, Bergh, Per‐Olof, Adiels, Martin, Turkez, Hasan, Taskinen, Marja‐Riitta, Bosley, Jim, Marschall, Hanns‐Ulrich, Nielsen, Jens, Uhlén, Mathias, Borén, Jan, Mardinoglu, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184219/
https://www.ncbi.nlm.nih.gov/pubmed/32337855
http://dx.doi.org/10.15252/msb.209495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184219/
https://www.ncbi.nlm.nih.gov/pubmed/32337855
http://dx.doi.org/10.15252/msb.209495

Ejemplares similares